Nantahala Capital Management, LLC Tff Pharmaceuticals, Inc. Transaction History

Nantahala Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.86 - $9.65 $1.86 Million - $2.62 Million	-271,067 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.21 - $10.49 $697,567 - $1.01 Million	-96,750 Reduced 26.3%	271,067 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$8.48 - $13.61 $124,961 - $200,556	-14,736 Reduced 3.85%	367,817 $3.54 Million
Q1 2021 May 14, 2021	SELL	$12.96 - $19.75 $17.9 Million - $27.3 Million	-1,380,923 Reduced 78.31%	382,553 $5.19 Million
Q4 2020 Feb 16, 2021	SELL	$12.74 - $18.49 $3.43 Million - $4.98 Million	-269,512 Reduced 13.26%	1,763,476 $25.3 Million
Q3 2020 Nov 16, 2020	BUY	$5.86 - $18.47 $6.89 Million - $21.7 Million	1,176,471 Added 137.36%	2,032,988 $37.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.79 - $6.08 $1.05 Million - $1.69 Million	277,300 Added 47.87%	856,517 $4.93 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $5.36 $190,301 - $290,603	54,217 Added 10.33%	579,217 $2.22 Million
Q4 2019 Feb 14, 2020	BUY	$4.71 - $5.4 $2.47 Million - $2.84 Million	525,000 New	525,000 $2.81 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.